Federal Register / Vol. 46, No. 210 / Friday, October 30. 1961 / Notices 
53985 
agreed to permit an observer, designated 
by the NIH. to visit the facilities should 
choose to inspect the site. 
The principal investigator is Dr. Norm 
S.-C Lin. The work is to be performed at 
the Pl-LS level of containment at the 
research and development facility in 
South San Francisco. California 94060. 
0. Cetus Corporation 
On October 21, 1981 the Director. 
NIAID. on the recommendation of the 
RAC. approved requests from Cetus 
Corporation for the large scale culture of 
EKl host-vector systems containing 
plasmids coding for human alpha-1- 
interferon and human proinsulin. 
These requests were approved with 
the understanding that Cetus 
Corporation has agreed to permit an 
observer, designated by NIH. to visit the 
facilities if NIH should choose to inspect 
the site. 
The principal investigator is Dr. 
Michael Konrad. The work is to be 
performed at the Pl-LS level of 
containment at the Cetus Corporation 
facility in Berkeley. California 94710. 
m. Scbering Corporation 
On October 21, 1981 the Director, 
NIAID. on the recommendation of the 
RAC. approved a request from Sobering 
Corporation for the large scale culture of 
EKl host-vec'or systems containing 
plasmids coding for human leukocyte 
interferons. 
This request was approved with the 
understanding that Scaring 
Corporation has agreed to permit an 
observer, designated by N^. to visit the 
facilities if NIH should choose to inspect 
the site. 
The principal investigators for the 
project are Drs. Paul Leibowitz and 
Mark Finkelstein. The work is to be 
performed at the Pl-LS level of 
containment at the Schering Corporation 
facility in Bloomfield. New jersey 08003. 
IV. .Molecular Genetics. Inc. 
On October 21. 1981, the Director. 
NIAID. on the reconunendation of the 
R.\C. approved requests from Molecular 
Genetics. Inc., for the large scale culture 
of: 
1. EKl host-vector systems containing 
plasmids coding for the reverse 
transcriptase of the Avian Sarcoma 
'Virus. 
2. EKl host-vector systems containing 
plasmids coding for bovine growth 
hormone. 
The principal investigator for the 
reverse transcriptase project is Dr. john 
Weis. The principal investigator for the 
bovine growth hormone project is Dr. 
Richard A. Krzyzek. The work is to be 
performed at the Pl-LS level of 
containment at the facility in 
Minnetonka, Minnesota 55343. 
Dated: October 23. 1981. 
Richard M. Krause. 
Director, National Institute of Allergy and 
Infectious Diseases. National Institutes of 
Health. 
OMB's “Mandatory Information 
Requirements for Federal Assistance Program 
Announcements" (45 FR 39592) requires a 
statement concerning the ofTicial government 
programs contained in the Catalog of t^ederal 
Domestic Assistance. Normally NIH lists in 
its announcements the number and title of 
affected Individual programs for the guidance 
of the public. Because the guidance in this 
notice covers not only virtually every NIH 
program but also essentially every federal 
research program in which DNA recombinant 
molecule techniques could be used, it h:i8 
been determined to be not cost effective or in 
the public interest to attempt to list tiiese 
programs. Such a list would likely require 
several additional pages. In addition. NIH 
could not be certain that every federal 
program would be included as many federal 
agencies, as well as private organizations, 
both national and international, have elected 
to follow the .NIH Guidelines. In lieu of the 
individual program listing, NIH invites 
readers to direct questions to the information 
address above about whether individual 
programs listed in the Catalog of Federal 
Domestic Assistance are affected. 
Note. — NIH programs are not covered by 
OMB Circular A-95 because they fit the 
description of "programs not considered 
appropriate" in Section 8-{b){-{4) and (5) of 
that Circular. 
(FH Doc. U-312SS Filed 1U-28-S1: S«S dn) 
MiJNO cooe SIIO-OS-41 
[ 255 ] 
